A citation-based method for searching scientific literature

A Neri, C C Chang, L Lombardi, M Salina, P Corradini, A T Maiolo, R S Chaganti, R Dalla-Favera. Cell 1991
Times Cited: 402







List of shared articles



Times cited

Biological and Exploitable Crossroads for the Immune Response in Cancer and COVID-19.
Letizia Vitali, Alessandra Merlini, Federica Galvagno, Alessia Proment, Dario Sangiolo. Biomedicines 2022
0

NF-κB signaling as a driver of ageing.
F G Osorio, C Soria-Valles, O Santiago-Fernández, J M P Freije, C López-Otín. Int Rev Cell Mol Biol 2016
46

NF-κB, an active player in human cancers.
Yifeng Xia, Shen Shen, Inder M Verma. Cancer Immunol Res 2014
638

Regulation and function of NF-kappaB transcription factors in the immune system.
Sivakumar Vallabhapurapu, Michael Karin. Annu Rev Immunol 2009

Targeting transcription factors for therapeutic benefit.
Paul Brennan, Rossen Donev, Saman Hewamana. Mol Biosyst 2008
30


NF-kappaB activation in development and progression of cancer.
Jun-Ichiro Inoue, Jin Gohda, Taishin Akiyama, Kentaro Semba. Cancer Sci 2007
181

NF-kappa B signaling and carcinogenesis.
Takashi Okamoto, Takaomi Sanda, Kaori Asamitsu. Curr Pharm Des 2007
87



NF-kB in development and progression of human cancer.
Xavier Dolcet, David Llobet, Judit Pallares, Xavier Matias-Guiu. Virchows Arch 2005
703

Nuclear factor-kappaB modulation as a therapeutic approach in hematologic malignancies.
Amit Panwalkar, Srdan Verstovsek, Francis Giles. Cancer 2004
77